Page 3 - Ascular News Today

Cleveland Clinic researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol.

An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma (POAG), the most common type of glaucoma and the leading cause of irreversible blindness globally.

Researchers utilized an untargeted metabolomics technique to look for new compounds and pathways that may contribute to residual cardiovascular disease risk.

Every year, around 50,000 people in the United States experience cardiogenic shock -; a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood for the body's needs.

A recent study highlights the effectiveness of a multidisciplinary diabetes management program in reducing the risk of dementia in type 2 diabetes patients, emphasizing the importance of glycemic control for dementia prevention.

It’s news you’ll love for Valentine’s Day: a leading health expert says the dark chocolates and bubbly you bought your sweetheart may also improve their heart health.

Heart disease is the leading cause of death among women, and women who have complications during pregnancy, such as high blood pressure or gestational diabetes, have a significantly higher risk of heart disease and stroke later in life, according to a new scientific statement from the American Heart Association, published today in Circulation, the Association's flagship peer-reviewed journal.

David Gibson, 75, of Walbridge, a village within the Toledo metropolitan area, traveled 100 miles to undergo care with University Hospital’s Harrington Heart & Vascular Institute in Cleveland.

Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.

Eleven scientists leading the way in stroke research will be recognized during the American Stroke Association's International Stroke Conference 2024 for their exceptional professional achievements.